Digital therapeutics can increase the value of medicinal assets, driving differentiation and improving outcomes for patients. But are manufacturers prepared to capitalize on this significant untapped opportunity before the tech giants dominate?
Digital therapeutics as a combination therapy: Maximizing asset value and therapeutic outcomes